EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Double-blinded placebo-controlled clinical trial of prophylactic omeprazole in dogs treated surgically for acute thoracolumbar intervertebral disc extrusion

Jaya M Mehra, M Katherine Tolbert iD, Phillip Guadiano, Jörg M Steiner iD, George E Moore, Melissa J Lewis iD

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Jaya M Mehra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Intervertebral Disc Displacement, Intervertebral Disc, Dog Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American College of Veterinary Internal Medicine, Purina Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors are administered prophylactically in dogs treated surgically for acute thoracolumbar intervertebral disc extrusion (TL-IVDE). However, their efficacy in decreasing gastrointestinal (GI) complications is unknown. Hypothesis Omeprazole does not decrease the frequency of GI complications compared to placebo in dogs treated surgically for acute TL-IVDE. Animals Thirty-seven client-owned dogs undergoing hemilaminectomy for acute TL-IVDE.

Methods

Randomized double-blinded placebo-controlled prospective clinical trial. Dogs received PO placebo or omeprazole at 1 mg/kg q12h for 5 days during hospitalization. Development of GI signs (e.g., diarrhea, vomiting, regurgitation, hematochezia, melena) was recorded daily. Clinicopathologic testing performed during hospitalization and at 2 and 4-week re-evaluations included: fecal occult blood, PCV, blood urea nitrogen/creatinine ratio, fecal calprotectin, canine pancreatic lipase immunoreactivity and fecal alpha-1 proteinase inhibitor concentrations. Omeprazole and placebo groups were compared using chi-squared or Fisher's exact tests.

Results

Gastrointestinal signs developed in 10/20 (50%) dogs in the omeprazole group and in 7/17 (41%) dogs in the placebo group (P = .59). Diarrhea was common (8/20 omeprazole, 5/17 placebo), hematochezia was rare (1/20 omeprazole, 1/17 placebo); melena was not observed. Clinicopathologic evidence suggestive of bleeding was present in 9/20 dogs treated with omeprazole and in 11/17 dogs that received placebo (P = .23). Fecal occult blood positivity was more common in dogs with GI signs (P = .03). Canine pancreatic lipase immunoreactivity was higher during hospitalization compared to re-evaluations (P = .01). Conclusions and Clinical Importance Short-term, prophylactic omeprazole treatment did not decrease clinically detectable GI complications in dogs with acute TL-IVDE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intervertebral Disc DisplacementIntervertebral DiscDog DiseasesDogsAnimalsOmeprazoleProspective StudiesGastrointestinal HemorrhageMelenaDiarrheaLipase

Stichwörter der Autor:innen

anti-inflammatorycaninediarrheagastrointestinal complicationsproton pump inhibitorsspinal cord injury

Substanzen

OmeprazoleLipase

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.
  • Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA.
  • Department of Veterinary Administration, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.

ORCID-Profile: M Katherine Tolbert, Jörg M Steiner, Melissa J Lewis

Förderung

  • American College of Veterinary Internal Medicine
  • Purina Institute

Zitieren

APA

Mehra, J. M., Tolbert, M. K., Guadiano, P., Steiner, J. M., Moore, G. E., & Lewis, M. J. (2023). Double-blinded placebo-controlled clinical trial of prophylactic omeprazole in dogs treated surgically for acute thoracolumbar intervertebral disc extrusion. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16642

Vancouver

Mehra JM, Tolbert MK, Guadiano P, Steiner JM, Moore GE, Lewis MJ. Double-blinded placebo-controlled clinical trial of prophylactic omeprazole in dogs treated surgically for acute thoracolumbar intervertebral disc extrusion. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16642

BibTeX
@article{Mehra2023,
  author = {Mehra, Jaya M and Tolbert, M Katherine and Guadiano, Phillip and Steiner, Jörg M and Moore, George E and Lewis, Melissa J},
  title = {Double-blinded placebo-controlled clinical trial of prophylactic omeprazole in dogs treated surgically for acute thoracolumbar intervertebral disc extrusion},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16642}
}
Kostenlos starten →